Anti-KDM4D / JMJD2D antibody [EPR25241-24]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal KDM4D / JMJD2D antibody. Suitable for ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples.
View Alternative Names
JHDM3D, JMJD2D, KDM4D, Lysine-specific demethylase 4D, JmjC domain-containing histone demethylation protein 3D, Jumonji domain-containing protein 2D, [histone H3]-trimethyl-L-lysine(9) demethylase 4D
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (AB289667)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa cells labeling KDM4D / JMJD2D with ab289667 at 1/500 dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed secondary antibody at 1/1000 dilution (Green). Confocal image showing nuclear staining in HeLa cell line. The nuclear counterstain is DAPI (Blue). Tubulin is labeled using ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution (Red).
Secondary antibody only control : Used PBS instead of primary antibody, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed secondary antibody at 1/1000 dilution.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (AB289667)
Flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized HeLa (human cervix adenocarcinoma epithelial cell line) cells labeling KDM4D / JMJD2D with ab289667 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) isotype control (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081)at 1/2000 dilution was used as the secondary antibody.
- IP
Lab
Immunoprecipitation - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (AB289667)
KDM4D / JMJD2D was immunoprecipitated from HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate with ab289667 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed from the immunoprecipitate using ab289667 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab289667 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab289667 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (ab289667)
Predicted band size: 59 kDa
Observed band size: 60 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (AB289667)
5% NFDM/TBST was used as a dilution and blocking buffer.
Low expression : ovary, spleen (PMID : 21293030).
All lanes:
Western blot - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (ab289667) at 1/1000 dilution
Lane 1:
Human testis tissue lysate at 20 µg
Lane 2:
Human ovary tissue lysate at 20 µg
Lane 3:
Human spleen tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG (Merck DC03L) at 1/2000 dilution
Predicted band size: 59 kDa
Observed band size: 60 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (AB289667)
Lysates were made freshly and used in the WB test immediately to minimize protein degradation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KDM4D / JMJD2D antibody [EPR25241-24] (ab289667) at 1/1000 dilution
All lanes:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 59 kDa
Observed band size: 60 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-KDM4D / JMJD2D antibody [EPR25241-24] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com